|
1
|
Cioffi A, Reichert S, Antonescu CR and
Maki RG: Angiosarcomas and other sarcomas of endothelial origin.
Hematol Oncol Clin North Am. 27:975–988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pandit SA, Fiedler PN and Westcott JL:
Primary angiosarcoma of the lung. Ann Diagn Pathol. 9:302–304.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adem C, Aubry MC, Tazelaar HD and Myers
JL: Metastatic angiosarcoma masquerading as diffuse pulmonary
hemorrhage: Clinicopathologic analysis of 7 new patients. Arch
Pathol Lab Med. 125:1562–1565. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YB, Guo LC, Yang L, Feng W, Zhang XQ,
Ling CH, Ji C and Huang JA: Angiosarcoma of the lung: 2 cases
report and literature reviewed. Lung Cancer. 70:352–356. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilson R, Glaros S, Brown RK, Michael C
and Reisman D: Complete radiographic response of primary pulmonary
angiosarcomas following gemcitabine and taxotere. Lung Cancer.
61:131–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aramini B, Masciale V, Bianchi D,
Manfredini B, Banchelli F, D'Amico R, Bertolini F, Dominici M,
Morandi U and Maiorana A: ALDH Expression in Angiosarcoma of the
Lung: A Potential Marker of Aggressiveness? Front Med (Lausanne).
7:5441582020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Falk AT, Moureau-Zabotto L, Ouali M, Penel
N, Italiano A, Bay JO, Olivier T, Sunyach MP, Boudou-Roquette P,
Salas S, et al: Effect on survival of local ablative treatment of
metastases from sarcomas: A study of the French sarcoma group. Clin
Oncol (R Coll Radiol). 27:48–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Y, Wang WS, Wang HL, Liu J and Lu YG:
Treatment of Epithelioid angiosarcoma with Topical ALA-PDT in the
course of surgery. Photodiagnosis Photodyn Ther. 19:153–155. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sasaki R, Soejima T, Kishi K, Imajo Y,
Hirota S, Kamikonya N, Murakami M, Kawabe T, Ejima Y, Matsumoto A
and Sugimura K: Angiosarcoma treated with radiotherapy: Impact of
tumor type and size on outcome. Int J Radiat Oncol Biol Phys.
52:1032–1040. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gebhardt C, Ziegler B, Stadler S, Goerdt S
and Utikal J: Complete remission of treatment-refractory advanced
angiosarcoma of the scalp by protracted intralesional interleukin-2
therapy. Br J Dermatol. 172:1156–1158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Young RJ, Woll PJ, Staton CA, Reed MW and
Brown NJ: Vascular-targeted agents for the treatment of
angiosarcoma. Cancer Chemother Pharmacol. 73:259–270. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosenbaum E, Antonescu CR, Smith S, Bradic
M, Kashani D, Richards AL, Donoghue M, Kelly CM, Nacev B, Chan JE,
et al: Clinical, genomic, and transcriptomic correlates of response
to immune checkpoint blockade-based therapy in a cohort of patients
with angiosarcoma treated at a single center. J Immunother Cancer.
10:e0041492022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sturm EC, Marasco IS and Katz SC:
Multidisciplinary management of angiosarcoma-A review. J Surg Res.
257:213–220. 2021. View Article : Google Scholar : PubMed/NCBI
|
